research use only
Cat.No.S8936
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel Potassium Channel GABA Receptor TRP Channel ATPase |
|---|---|
| Other VDAC Inhibitors | VBIT-4 NSC15364 DIDS sodium salt |
| Molecular Weight | 417.50 | Formula | C25H27N3O3 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2089227-65-4 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CN(CCC1(C(=O)NCC(=O)O)NC2=CC=CC=C2)CC3=CC=CC4=CC=CC=C43 | ||
|
In vitro |
DMSO
: 83 mg/mL
(198.8 mM)
Water : 2 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
VDAC1
|
|---|---|
| In vitro |
VBIT-12 directly interacts with purified VDAC1 and reduces its channel conductance. This compound interferes with VDAC1 oligomerisation and thus with the pro-apoptotic action of VDAC1 when the levels of expression are abnormal, but has no effect on cells under physiological conditions. |
| In vivo |
The effect of VBIT-12 on induction of startle habituation and prepulse inhibition (PPI) in animals is examined via novelty suppressed feeding test, sweet preference model of anhedonia and forced swim test (FST) model for despair. This compound interacts with the Voltage-Dependent Anion Channel (VDAC) and can be used for the treatment of central nervous system (CNS) disorders and diseases. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.